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Background
Recovery of gut mucosal immune system is slow and
incomplete during HAART therapy, leading to elevated
inflammation rates, increased mitochondrial damage and
the pathogenesis of replicatively competent escape muta-
tions. A recent study of Ganeden BC30, Bacillus coagulans
GBI-30, demonstrated safety, increased CD4+ counts in
patients on HARRT, and a significant increase in CD69
and maturation of dendritic cells in vitro. Lactobacillus
rhamnosus GR-1 and Lactobacillus reuteri RC-14 demon-
strate efficacy in treating naïve HIV patients against gas-
trointestinal and urogenital infections . Restoration of viral
host restrictive factors of Th17 cell lines in GALT may
prevent the evolving viral diversity, provoking increased
CD4 presentation and regulation of inflammatory cytokine
levels responsible for increased viral replication.
Methods
Metagenomic sequencing analysis has shown alternations
in intestinal microbiota in HIV patients. Measurements of
immunological parameters including Serum cytokine
levels and total serum IgE levels (CD4 lymphocyte count,
CBC, levels of TNFÎ±, NFAT, IL-12, IL-10, and G-CSF
[Kim, et.al. 2006]) were measured in studies reviewed here.
Results
A recent study of Ganeden BC30, bacillus coagulans
GBI-30, 6086 demonstrated safety, and an increase in %
CD4, a significant increase in CD69 activation and
maturation of dendritic cells in HIV patients on
HARRT and improvement in GI function. Lactobacillus
rhamnosus GR-1 and Lactobacillus reuteri RC-14 have
demonstrated efficacy treating naïve HIV patients gas-
trointestinal and urogenital infections and prevent diar-
rhea and increased CD4 T-lymphocyte percentages in
HIV patients.
Conclusions
Intestinal microbiota are integral to the homeostasis and
functioning of immune cells. The loss of intestinal flora by
HIV infection is severely detrimental to the recombination
of CD4 cells. Restoring proper biodiversity in the gut by
safe, efficacious probiotics demonstrates promise in
increasing Th17 cells by restoring GALT. GanedenBC30
may down regulate TNF-a and other inflammatory cyto-
kines and mitigate ARV-related SAEs.
Data suggests that replenishment of Th17 CD4 cells in
the gut mucosa during HAART correlates with improved
function of the gut mucosal immune system and its func-
tion.. Studies by NIH of probiotics to lower microbial
translocation and immune activation in HIV-infected
adolescents.
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